Hiroyuki Okuzawa - Daiichi Sankyo President
| DSNKY Stock | USD 30.58 0.97 3.28% |
President
Hiroyuki Okuzawa is Executive Officer and Presidentident of ASCA Company of Daiichi Sankyo Co since 2018.
| Age | 61 |
| Tenure | 6 years |
| Phone | 81 3 6225 1111 |
| Web | https://www.daiichisankyo.com |
Daiichi Sankyo Management Efficiency
The company has return on total asset (ROA) of 0.0209 % which means that it generated a profit of $0.0209 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0432 %, meaning that it generated $0.0432 on every $100 dollars invested by stockholders. Daiichi Sankyo's management efficiency ratios could be used to measure how well Daiichi Sankyo manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Andrew Dickinson | Gilead Sciences | 54 | |
| William Chase | AbbVie Inc | 50 | |
| Julie Gerberding | Merck Company | 64 | |
| Steven Mizell | Merck Company | 60 | |
| Menelas Pangalos | AstraZeneca PLC ADR | 57 | |
| Michael Nally | Merck Company | 44 | |
| Franklin Clyburn | Merck Company | 56 | |
| Michael Sneed | Johnson Johnson | 60 | |
| Hal Barron | GlaxoSmithKline PLC ADR | 58 | |
| Robert Davis | Merck Company | 54 | |
| Jeffrey Stewart | AbbVie Inc | 55 | |
| Jose Baselga | AstraZeneca PLC ADR | 58 | |
| Miguel Montblanch | Grifols SA ADR | 64 | |
| Louis Schmukler | Bristol Myers Squibb | 65 | |
| Esteban Santos | Amgen Inc | 56 | |
| Cristal Downing | Merck Company | 55 | |
| David Fredrickson | AstraZeneca PLC ADR | N/A | |
| Nicholas Donoghoe | AbbVie Inc | 37 | |
| Regis Simard | GlaxoSmithKline PLC ADR | N/A | |
| Elizabeth Mily | Bristol Myers Squibb | 53 | |
| Sandra Leung | Bristol Myers Squibb | 60 | |
Management Performance
| Return On Equity | 0.0432 | |||
| Return On Asset | 0.0209 |
Daiichi Sankyo Leadership Team
Elected by the shareholders, the Daiichi Sankyo's board of directors comprises two types of representatives: Daiichi Sankyo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Daiichi. The board's role is to monitor Daiichi Sankyo's management team and ensure that shareholders' interests are well served. Daiichi Sankyo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Daiichi Sankyo's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Masahiko Ohtsuki, Executive Officer, Senior Director of Research in Main Research & Development Unit | ||
| Junichi Onuma, VP Department | ||
| Hiroyuki Okuzawa, Executive Officer and Presidentident of ASCA Company | ||
| Hideyuki Haruyama, Co Adviser | ||
| Akio Sakurai, Corp Unit | ||
| Yoshinori Kaneshima, Corp Unit | ||
| Kentaro Asakura, VP Department | ||
| Sunao DVM, Group Pres | ||
| Naoto Tsukaguchi, Corp Counsel | ||
| Takashi Matsumoto, Co HR | ||
| Marielle MD, Global Devel |
Daiichi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Daiichi Sankyo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0432 | |||
| Return On Asset | 0.0209 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 57.82 B | |||
| Shares Outstanding | 1.92 B | |||
| Shares Owned By Institutions | 0.21 % | |||
| Price To Earning | 92.74 X | |||
| Price To Book | 5.98 X | |||
| Price To Sales | 0.06 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Daiichi Pink Sheet Analysis
When running Daiichi Sankyo's price analysis, check to measure Daiichi Sankyo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daiichi Sankyo is operating at the current time. Most of Daiichi Sankyo's value examination focuses on studying past and present price action to predict the probability of Daiichi Sankyo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daiichi Sankyo's price. Additionally, you may evaluate how the addition of Daiichi Sankyo to your portfolios can decrease your overall portfolio volatility.